HER2DX genomic assay in HER2-positive early breast cancer treated with trastuzumab and pertuzumab: A correlative analysis from a real-world cohort. - de Castro BA; Cobo S; Pena MA; Malillos JP; Rendo CR; López EP; Castillo O; Sirenko V; Aguirre A; Blasco P; Martínez LC; Galván P; et al. (Breast (Edinburgh, Scotland), 2026)